SDG 3. GOOD HEALTH & WELL-BEING DRUG DESIGN Valence Discovery

Valence Discovery: transforming AI-enabled drug design with ‘few-shot learning’

April 5, 2021, by Darcy Jimenez

Artificial intelligence (AI) has become an increasingly popular tool for drug companies discovering and designing new therapies. According to analysis by Deloitte, the AI market ...

Read more on Pharmaceutical Technology


SDG 3. GOOD HEALTH & WELL-BEING Valence Discovery

AI drug discovery firm Valence joins Parkinson’s disease push

March 15, 2021, by Phil Taylor

Canada’s Valence Discovery has joined a University of Montreal-led project to try to find new drugs to treat the involuntary movement complications that can accompany ...

Read more on pharmaphorum